Biocare Medical is a biotechnology company specializing in the innovation, development, manufacturing, and distribution of advanced automated immunohistochemistry (IHC) and molecular pathology instrumentation and reagents. They serve clinical laboratories, research institutions, and pharmaceutical partners globally, focusing on providing precise and reliable solutions for cancer diagnostics and research. Their portfolio includes a comprehensive range of antibodies, detection systems, and the ONCORE Pro and intelliPATH automated staining systems.
Serves as the central hub for research and development, manufacturing, global operations, sales, marketing, and corporate administration for its IHC and molecular pathology solutions.
The facility is equipped with state-of-the-art laboratories for R&D, quality control, and manufacturing of sensitive biological reagents and automated staining instrumentation. It likely includes specialized cleanroom environments compliant with Good Manufacturing Practices (GMP) and advanced scientific equipment.
Biocare Medical's Pacheco headquarters fosters an environment centered on innovation, scientific excellence, and collaboration. Employees are typically engaged in cutting-edge research, development, and manufacturing of diagnostic solutions, working together to advance cancer diagnostics. The culture emphasizes precision, quality, customer focus, and a shared commitment to improving patient outcomes.
The Pacheco facility is pivotal as Biocare Medical's global headquarters, housing its core research and development labs, advanced manufacturing units, and corporate leadership. It's the nerve center for innovation in IHC and molecular pathology, driving the development of products distributed worldwide to aid in disease diagnosis and treatment strategies.
Biocare Medical has a significant global presence, making its advanced IHC and molecular pathology solutions available to customers in numerous countries worldwide. This is achieved primarily through an extensive network of international distributors, complemented by direct sales efforts in key markets. This structure ensures that clinical laboratories, research institutions, and pharmaceutical companies globally have access to their innovative instruments, reagents, and dedicated support services. Their global functions supported through this network include sales, marketing, distribution, technical support, and application training to facilitate cancer diagnostics and research across diverse geographical regions.
60 Berry Drive
Pacheco
CA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Biocare Medical' leadership includes:
Biocare Medical has been backed by several prominent investors over the years, including:
Over the past 12 months, Biocare Medical has focused on strengthening its leadership team, particularly in commercial operations and global supply chain management. Key strategic appointments have been made to drive growth and operational excellence. No significant executive departures have been publicly announced during this period.
Discover the tools Biocare Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Biocare Medical typically utilizes an email format combining the first initial of an employee's name with their full last name, followed by the @biocare.net domain. For instance, an employee named Jane Doe would likely have an email address such as 'jdoe@biocare.net'. This is a common structure in the biotechnology and medical device industries.
[first_initial][last]@biocare.net
Format
jdoe@biocare.net
Example
85%
Success rate
Business Wire • May 22, 2024
Biocare Medical announced the commercial launch of its [Ki-67 Rabbit Monoclonal Antibody (Clone BCI-49) IVD], an essential tool for pathologists. This antibody aids in assessing cancer cell proliferation, which is critical for determining prognosis and guiding treatment decisions, and is validated for use on Biocare's staining platforms....more
Business Wire • March 26, 2024
At the USCAP 2024 annual meeting, Biocare Medical showcased a range of novel antibodies aimed at advancing cancer diagnostics. These new tools support precision medicine by enabling more accurate tumor profiling and identification of therapeutic targets, underscoring Biocare's commitment to innovation in pathology....more
Business Wire • January 16, 2024
Biocare Medical introduced its next-generation ONCORE Pro X, a fully automated slide staining system for Immunohistochemistry (IHC) and In Situ Hybridization (ISH). This system is engineered to improve laboratory workflow efficiency, deliver high-quality, consistent staining results, and offer advanced features for modern pathology labs....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Biocare Medical, are just a search away.